Three urgent needs in the battle against COVID-19: specific medications, information and acceptance of Pandemic

Authors

  • Luiz Carlos de Abreu aProfessor Titular. Departamento de Educação Integrada em Saúde. Universidade Federal do Espírito Santo, Brazil; bAdjunct Professor. University of Limerick, Ireland; cBrazil and Ireland COVID-19 Observatory; fCambridge Health Alliance affiliated with Harvard Medical School, Boston, USA;
  • Rodrigo Daminello Raimundo cBrazil and Ireland COVID-19 Observatory;
  • Andrés Ricardo Pérez-Riera cBrazil and Ireland COVID-19 Observatory;
  • Italla Maria Pinheiro Bezerra cBrazil and Ireland COVID-19 Observatory; dEscola Superior de Ciências da Santa Casa de Misericórdia de Vitória, EMESCAM;
  • Elisa Tristan-Cheever cBrazil and Ireland COVID-19 Observatory; dEscola Superior de Ciências da Santa Casa de Misericórdia de Vitória, EMESCAM; fCambridge Health Alliance affiliated with Harvard Medical School, Boston, USA;
  • Hani Khalil Atrash gRollins School of Public Health. Emory University Atlanta, USA.

DOI:

https://doi.org/10.36311/jhgd.v31.12794

Keywords:

COVID-19, lethality, mortal, time-series

Abstract

The first confirmed case of COVID-19 was notified to the Brazilian Ministry of Health on February 26, 2020. On November 20, 2021, by the end of Epidemiological Week-46 (EW-46) 257,168,692 confirmed cases of COVID-19 reported worldwide. Among the countries with the highest number of accumulated cases the United States of America ranks number one (47,701,872), followed by India (34,510,413), Brazil (22,012,150), the United Kingdom (9,857,658), and Russia (9,135,149). Concerning deaths, 5,146,467 were confirmed worldwide until November 20, 2021. The United States was the country with the highest accumulated number of deaths (771,013), followed by Brazil (612,587), India (465,662), Mexico (292,145), and Russia (257,891).

Downloads

Download data is not yet available.

References

Kobilov B, Rouen E, Serafeim G. Predictable country-level bias in the reporting of COVID-19 deaths. Journal of Government and Economics 2021; 2: 100012. https://doi.org/10.1016/j.jge.2021.100012

Medronho R de A, Ortiz Valencia LI, Fortes B de PMD, Braga RCC, Ribeiro S do V. Análise espacial da soroprevalência da hepatite A em crianças de uma região carente de Duque de Caxias, RJ, Brasil. Rev Bras Epidemiol 2003; 6: 328–34. https://doi.org/10.1590/S1415-790X2003000400007

Rouquayrol MZ, Almeida Filho N de. Epidemiologia & Saúde. Rio de Janeiro: Medsi; 2003.

Ministério da Saúde. Boletim Epidemiológico Especial: Doença pelo Coronavírus – Covid-19. ©2020. Disponível em: https://www.gov.br/saude/pt-br/media/pdf/2021/novembro/19/boletim_epidemiologico_covid_89_29nov21_fig37nv.pdf>

WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int (accessed November 24, 2021).

Abreu LC. The Path Of Humanity In The Pandemic Of Covid-19: The Choice Of The Realistic, Optimist Or Pessimist Scenario. J Hum Growth Dev. 2021; 31: 05–8. https://doi.org/10.36311/jhgd.v31.11683

O que a única vacina europeia de vírus inativados contra a COVID-19 tem a oferecer? UNA-SUS - Especial COVID-19. https://www.unasus.gov.br/especial/covid19/markdown/403 (accessed November 24, 2021).

Taylor A. What’s the Valneva COVID-19 vaccine, the French shot that’s supposed to be “variant proof”? The Conversation. http://theconversation.com/whats-the-valneva-covid-19-vaccine-the-french-shot-thats-supposed-to-be-variant-proof-160345 (accessed November 24, 2021).

Sobre anticorpos neutralizantes e a CoronaVac. Jornal da USP 2021. https://jornal.usp.br/artigos/sobre-anticorpos-neutralizantes-e-a-coronavac/ (accessed November 24, 2021).

Peng P, Deng H, Hu J, Wei X, Xue J, Li T, et al. Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell Discov 2021; 7: 68. https://doi.org/10.1038/s41421-021-00311-z

Franco R, Serrano-Marin J. Two urgent needs in the battle against COVID-19. Open Science Framework; 2021. https://doi.org/10.31219/osf.io/8fkbg

Aguiar MM, Barros MNS, Macedo A, Puccia MIR, Pereira AT. COVID-19 fear scale – translation and validation into Brazilian portuguese. J Hum Growth Dev. 2021; 31(3): 376-386. DOI: 10.36311/jhgd.v31.12604

Lopes-Júnior LC, Souza TM, Sobreira LB, Daleprane CLV, Denadai IR, Martins NB, Dall’orto TLC, Rabelo LC, Martins EA, Silva VR, Silva FM. Analysis of vaccination coverage during the COVID-19 pandemic in Vitória, Brazil. J Hum Growth Dev. 2021; 31(3):387-397. DOI: 10.36311/jhgd.v31.12122

Guarnieri CS, Sousa LVA, Paiva LS, Morais TC, Ribeiro MAL, Ribeiro MR, Monteiro CBM. COVID-19 mortality and lethality in the State of Pará, legal Amazon, Brazil. J Hum Growth Dev. 2021; 31(3):398-404. DOI: 10.36311/jhgd.v31.12605JHGD

Leitão FNC, Ferreira CRT, de Abreu KL, de Deus MBB, Junior HM, Morais MJD. Effects of the social isolation generated by Covid-19 on the quality of life of the population in Rio Branco - Acre and Santo André - São Paulo, Brazil. J Hum Growth Dev. 2021; 31(3):405-413. DOI: 10.36311/jhgd.v31.12609

Lima DL, Morais TC, Daboin BG, Cavalcanti MPE, Mesaroch A, Silva HMR, Guarnieri CS, Monteiro CBM, Abreu LC. Epidemiological perspective of the evolution of the COVID-19 pandemic in Amapá State, Northern Brazil. J Hum Growth Dev. 2021; 31(3):414-424. DOI: 10.36311/jhgd.v31.126100

Assis EL, Morais MJD, Eichemberg JO, Assis VRA, Junior HM, Deus MBB, Abreu LC. Evolution of COVID-19 during the epidemiological week 16 to 53 of 2020 in the state of Acre Western Amazonia, Brazil. J Hum Growth Dev. 2021; 31(3):425-435. DOI: 10.36311/jhgd.v31.12611JHGD

Martire Junior L, Morais TC, Eichemberg JO, Pereira JEG, Cavalcanti MPE, Pereira GAV, Silva HMR, Jacintho LC, Abreu LC. Lethality and mortality of COVID-19 in an important industrial center in Latin America, region of Grande ABC, São Paulo. J Hum Growth Dev. 2021; 31(3):436-446. DOI: 10.36311/jhgd.v31.12612JHGD

Valenzuela EV, Morais TC, Daboin BG, Cavalcanti MPE, Portugal IBM, Souza ISS, Ribeiro MAL, Monteiro CBM, Abreu LC. Evolution of mortality and lethality due to COVID-19 in the State of Roraima, Brazil, from march 2020 to july 2021. J Hum Growth Dev. 2021; 31(3):447-457. DOI: 10.36311/jhgd.v31.12184JHGD

Ferreira CRT, Leitão FNC, Deus MBB,Bezerra IMP, Deus RRB, Morais MJD. Sleep quality during home distancing in the COVID-19 pandemic in the Western Amazon. J Hum Growth Dev. 2021; 31(3):458-464. DOI: 10.36311/jhgd.v31.12606JHGD

Souza DCL, Guimarães RB, Carvalho AAS. Guillain-Barre syndrome related to COVID-19: muscle and nerve biopsy findings. J Hum Growth Dev. 2021; 31(3):465-469. DOI: 10.36311/jhgd.v31.12183

Silva AP, Pacheco LMF, Leitão FNC, Cavalcanti MPE, Rocha JBF, de Araújo Moraes SDT. Mental health status and quality of life of people with disabilities in social isolation. J Hum Growth Dev. 2021; 31(3):470-475. DOI: 10.36311/jhgd.v31.12619

Natário AJ, Veiga GL, Lima VL, Gascón T, Pinheiro JCS, Raimundo JRS, Alves BCA, Perez MM, Rodrigues CGBO, Sant’Anna AVL, Peres MC, Gois KC, Zambrano LI, Sperança MA, Sobrinho GR, Fonseca FLA. The influence of social isolation on the incidence of positivity in COVID-19 tests in a metropolitan region of São Paulo, Brazil. J Hum Growth Dev. 2021; 31(3):476-483. DOI:10.36311/jhgd.v31.12656

Stolf MT, Santos NL, D’Angelo I, Del Bianco N, Giaconi C, Capellini SA. Performance of early literacy students in cognitive-linguistic skills during the pandemic. J Hum Growth Dev. 2021; 31(3):484-490. DOI: 10.36311/jhgd.v31.12668

Abreu LC, Elmusharaf K, Siqueira CEG. A time-series ecological study protocol to analyze trends of incidence, mortality, lethality of COVID-19 in Brazil. J Hum Growth Dev. 2021; 31(3):491-495. DOI: 10.36311/jhgd.v31.12667

Cesar AEM, Daboin BEG, Morais TC, Portugal I, Echeimberg JO, Rodrigues LMR, Jacintho LC, Raimundo RD, Elmusharaf K, Siqueira CE. Analysis of COVID-19 mortality and case-fatality in a low-income region: an ecological time-series study in Tocantins, Brazilian Amazon. J Hum Growth Dev. 2021; 31(3):496-506. DOI: 10.36311/jhgd.v31.12744

de Sousa CDK, Morais TC, Daboin BEG, Portugal I, Cavalcanti MPE, Echeimberg JO, Jacintho LC, Raimundo RD, Elmusharaf K, Siqueira CE. Epidemiological profile of COVID-19 in the State of Espírito Santo, Brazil, from march 2020 to june 2021. J Hum Growth Dev. 2021; 31(3):507-520. DOI:10.36311/jhgd.v31.12770

Trivilato RA, Morais TC, Daboin BEG, Cavalcanti MPE, Jacintho LC, Raimundo RD, Echeimberg JO, Elmusharaf K, Siqueira CE, Figueiredo JL. Mortality and case fatality rates of COVID-19 in the State of Goiás, Brazil. J Hum Growth Dev. 2021; 31(3):521-532. DOI: 10.36311/jhgd.v31.12781

Marchiori JS, de Oliveira MAS, Bezerra IMP. COVID-19 and its relationship with kidney diseases: a scope review. J Hum Growth Dev. 2021; 31(3):533-548. DOI: 10.36311/jhgd.v31.12782

Junior DS, Morais TC, Portugal I, Cavalcanti MPE, Daboin BEG, Raimundo RD, Jacintho LC, Echeimberg JO, Elmusharaf K, Siqueira CE. Trends in COVID-19 mortality and case-fatality rate in the State of Paraná, South Brazil: spatiotemporal analysis over one year of the Pandemic. J Hum Growth Dev. 2021; 31(3):549-561. DOI: 10.36311/jhgd.v31.12792

Downloads

Published

2021-12-01

Issue

Vol. 31 No. 3 (2021)

Section

EDITORIAL

License

Copyright (c) 2021 Abreu LC, Raimundo RD, Pérez-Riera AR, Bezerra IMP, Tristan-Cheever E, Atrash HK

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.